FDA Inspection 1238116 — Garaventa (Canada), Ltd.

Garaventa (Canada), Ltd. — FEI 3002807131

The FDA completed an inspection of Garaventa (Canada), Ltd. on May 9, 2024 in Surrey. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 9, 2024
Fiscal Year
2024
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Surrey (Canada)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
323521 CFR 820.72(a)Equipment control activity documentation
48621 CFR 820.50(a)Evaluation of suppliers, contractors, etc., requirements

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.